Concepedia
Statistics
Publications
86
Citations
9.4K
Authors
14
Location
Cambridge, United Kingdom
Abzena (United Kingdom) is a company institution in Cambridge, United Kingdom known for pharmacology, oncology, and medicine.
Top concepts
PharmacologyPharmacyAntibody EngineeringCancer PharmacologyDrug DeliveryAntibody ConjugatesAntibody ConjugationAntibody-drug ConjugatesAntibody-drug Conjugate TherapyMedicinal Chemistry
Abzena (United Kingdom), United Kingdom
10 publications · 728 citations
7
h-index
22 publications · 472 citations
5 publications · 126 citations
5
5 publications · 214 citations
4
4 publications · 256 citations
1–5 of 14
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 423 citations
Medicine, Immunology, Oncology +16
SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer
Eiki Ichihara, David Westover, Catherine B. Meador et al. · Cancer Research · 2017 · 143 citations
Medicine, Oncology, Pharmacology +17
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker
Marta Poblocka, Akang Leonard Bassey, Victoria M. Smith et al. · Scientific Reports · 2021 · 129 citations · Full text
Pharmacy, Pharmaceutics, Pharmacology +17
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
Sylvie M. Guichard, Jon Curwen, Teeru Bihani et al. · Molecular Cancer Therapeutics · 2015 · 125 citations · Full text
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
Penny Bryant, Martin Pabst, George Badescu et al. · Molecular Pharmaceutics · 2015 · 122 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
1–5 of 86